These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1631792)
1. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate. Tsuda H; Miyata T; Iwanaga S; Yamamoto T Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792 [TBL] [Abstract][Full Text] [Related]
2. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Binnema DJ; Dooijewaard G; Turion PN Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069 [TBL] [Abstract][Full Text] [Related]
3. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization of a variant prekallikrein (PK Zürich). Wuillemin WA; Furlan M; von Felten A; Lämmle B Thromb Haemost; 1993 Sep; 70(3):427-32. PubMed ID: 8259543 [TBL] [Abstract][Full Text] [Related]
5. The contact-system dependent plasminogen activator from human plasma: identification and characterization. Binnema DJ; Dooijewaard G; van Iersel JJ; Turion PN; Kluft C Thromb Haemost; 1990 Nov; 64(3):390-7. PubMed ID: 2128968 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic studies in 13 unrelated families with factor XII deficiency. Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558 [TBL] [Abstract][Full Text] [Related]
7. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients. Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator-induced monocyte adhesion is modulated by kininogen, kallikrein, factor XII, and plasminogen. Li C; Gurewich V; Liu JN Exp Cell Res; 1996 Aug; 226(2):239-42. PubMed ID: 8806427 [TBL] [Abstract][Full Text] [Related]
9. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
10. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators. Fry ET; Mack DL; Sobel BE Thromb Haemost; 1989 Nov; 62(3):909-16. PubMed ID: 2512679 [TBL] [Abstract][Full Text] [Related]
11. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators. Castañon MM; Gamba C; Kordich LC Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
15. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related]
16. Dextran sulfate-dependent fibrinolysis in whole human plasma. Miles LA; Rothschild Z; Griffin JH J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600 [TBL] [Abstract][Full Text] [Related]
17. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII. Schousboe I; Rasmussen MS; Lintner R Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305 [TBL] [Abstract][Full Text] [Related]
18. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248 [TBL] [Abstract][Full Text] [Related]